1. The LJWG 2014 conference is funded through educational grants from AbbVie Ltd, Gilead Sciences Ltd and MSD Ltd and sponsored by Bristol-Myers Squibb. None of the sponsors has had any control over the agenda or content.

2. Hepatitis C in London: practical steps to elimination Monday 17 th November 2014 Guildhall, London

3. Co-Chairs: Cllr Victoria Borwick Deputy Mayor of London Dr Ashley Brown Consultant Hepatologist, St. Mary’s and Hammersmith Hospitals London and Honorary Senior Lecturer, Imperial College London Hepatitis C in London: practical steps to elimination

5. #LJWG2014

6. SESSION 1 Tools to eliminate

7. Dr Helen Harris Clinical Scientist & Research Associate, Public Health England Tackling Hepatitis what PHE modelling shows us

8. Dee Cunniffe Policy Lead & Co-facilitator London Joint Working Group on Substance Use and Hepatitis C Data collection and barriers in the system

9. Professor Sharon Hutchinson Professor of Epidemiology & Population Health Glasgow Caledonian University Health Protection Scotland How aspirations can be built and levels of performance can be assured: learning from the Scottish Action Plan

10. Mike Burns CEO & Operations Director CAIR Scotland Needle exchange impact on hepatitis C pathways

11. Dr Magdalena Harris Qualitative Sociologist London School of Hygiene & Tropical Medicine Supporting people who use drugs and providers: Hep C info and care

12. Claire Munro Co-facilitator London Joint Working Group on Substance Use and Hepatitis C The role of technology in supporting patient pathways

13. Danny Morris RCGP Clinical Lead Hepatitis B & C, Part 1 certificate RCGP training online: new training in short bites

14. QUESTIONS Dr Ashley Brown Consultant Hepatologist, St. Mary’s and Hammersmith Hospitals, London and Honorary Senior Lecturer, Imperial College London Hepatitis C in London: practical steps to elimination

15. REFRESHMENT BREAK Hepatitis C in London: practical steps to elimination

16. SESSION 2 Collaborate to eliminate

17. Dr Éamonn O’Moore Head of Health & Justice Health & Wellbeing Directorate Public Health England Producing a framework for hepatitis C through partnership working

18. David Badcock Head of Recovery Engagement Addaction The role of drug treatment providers in the care pathway: practical learning from the South-West

19. Professor Matt Hickman Professor of Public Health & Epidemiology University of Bristol Reducing transmission in PWID by scaling up drug treatment, OST and needle exchange services

20. Dr Ashley Brown Consultant Hepatologist, St. Mary’s and Hammersmith Hospitals, London and Honorary Senior Lecturer, Imperial College London The Updated LJWG Consensus

21. QUESTIONS Cllr Victoria Borwick Deputy Mayor of London Hepatitis C in London: practical steps to elimination

22. WORKSHOPS Hepatitis C policy development - East Crypt (adjacent to Livery Hall) How to reduce blockages in the system by implementing care pathways in collaboration with commissioners - West Crypt (walk through the East Crypt) The impact of new drug treatments on elimination - Livery Hall (main plenary) Community mobilisation: engaging users to support needle exchanges and peer-led groups - City Marketing Suite Conference Room (outside and right)

23. LUNCH Hepatitis C in London: practical steps to elimination

24. The LJWG 2014 conference is funded through educational grants from AbbVie Ltd, Gilead Sciences Ltd and MSD Ltd and sponsored by Bristol-Myers Squibb. None of the sponsors has had any control over the agenda or content.

25. Hepatitis C in London: practical steps to elimination WORKSHOP FEEDBACK Chair: Charles Gore President, World Hepatitis Alliance Chief Executive, Hepatitis C Trust

26. Dr Suman Verma Institute of Liver Studies King's College Hospital London The impact of new drugs on elimination

27. New Drugs for HCV - key messages A tornado of new drugs Combinations of drugs together work best Less role of interferon 8-12 weeks duration Real life is not as per the trials Access & affordability The future is bright but the timelines unclear…

28. Chris Kelly Assistant Head of Health & Justice Commissioning NHS England Hepatitis C policy development

29. Solutions to policy challenges Chris Kelly, NHS England 1. Low public and GP awareness – education programmes, campaigns, training 2. Policy deprioritisation – overarching policy initiatives eg Health Check, Outcomes Framework 3. Inflexible services/time pressures – care navigators, community prescribing, digital access to information 4. Opaque commissioning – clearer guidance, ensuring strategies in place for longer than duration of tenders, focusing on service delivery and integration

30. Emma Burke Alcohol & Drugs Programme Manager Public Health England How to reduce blockages in the system by implementing care pathways in collaboration with commissioners

31. Reducing blockages in the pathway Blockages: Lack of understanding commissioning & where the funding comes from No recourse to public funds Treatment too difficult to access Tension between local and national priorities Short-term planning and commissioning Skills and education all along the pathway (staff and service users, commissioners) Solutions: Clarify role of CCGs, NHSE & Local Authorities, and funding for new treatments London-wide Commissioning and pathways Deliver treatment ‘near the service user’ / in the community / possibly by pharmacist Need a national driver and long-term plans Education and formal training Build Peer-support and user voice

32. Mat Southwell Partner Coact Community mobilisation: engaging users to support needle exchanges and peer-led groups

33. Community Mobilisation Engaging people who use drugs to support needle exchanges & peer led groups Mat Southwell Partner Coact www.co-act.info

34. Community mobilisation NSPs Peer led NSPs Meaningful participation in traditional NSPs Secondary needle exchange Supplier engagement matsouthwell@co-act.info

35. Final panel Mike Burns CEO & Operations Director, CAIR Scotland Jim Conneely Hepatitis C Patient and Hepatitis C Trust outreach worker Professor Graham Foster Professor of Hepatology and Consultant Hepatologist, Bart’s and The Royal London Hospitals, London Professor Matt Hickman Professor of Public Health and Epidemiology, University of Bristol Peter Kohn Director, London Office of Clinical Commissioning Groups Dr Éamonn O’Moore Head of Health & Justice, Health & Wellbeing Directorate, Public Health England Dr Sally Porter Consultant in Addiction Psychiatry, South London and Maudsley NHS Foundation Trust, and Turning Point

36. The LJWG 2014 conference is funded through educational grants from AbbVie Ltd, Gilead Sciences Ltd and MSD Ltd and sponsored by Bristol-Myers Squibb. None of the sponsors has had any control over the agenda or content.